Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2019 | 14 | 0.80 | Why? |
| Disease Reservoirs | 4 | 2021 | 1672 | 0.70 | Why? |
| Zoonoses | 9 | 2021 | 3034 | 0.69 | Why? |
| Phytotherapy | 4 | 2018 | 743 | 0.66 | Why? |
| One Health | 2 | 2021 | 390 | 0.63 | Why? |
| Medicine, Ayurvedic | 1 | 2018 | 155 | 0.62 | Why? |
| Plant Preparations | 1 | 2018 | 276 | 0.53 | Why? |
| Plants, Medicinal | 4 | 2021 | 622 | 0.39 | Why? |
| Immunologic Factors | 4 | 2020 | 4206 | 0.35 | Why? |
| Phytochemicals | 5 | 2021 | 678 | 0.34 | Why? |
| Cat Diseases | 3 | 2021 | 539 | 0.31 | Why? |
| Animals, Domestic | 3 | 2021 | 272 | 0.29 | Why? |
| Plant Extracts | 4 | 2021 | 1514 | 0.25 | Why? |
| Viral Vaccines | 7 | 2020 | 7560 | 0.24 | Why? |
| Poultry Diseases | 2 | 2019 | 588 | 0.24 | Why? |
| Cats | 4 | 2021 | 1890 | 0.23 | Why? |
| Animals, Wild | 4 | 2021 | 1028 | 0.23 | Why? |
| Animals | 31 | 2021 | 78931 | 0.23 | Why? |
| Snakes | 1 | 2020 | 53 | 0.22 | Why? |
| Tigers | 1 | 2020 | 43 | 0.22 | Why? |
| Felidae | 1 | 2020 | 23 | 0.21 | Why? |
| Models, Animal | 2 | 2021 | 788 | 0.21 | Why? |
| Viverridae | 1 | 2020 | 225 | 0.21 | Why? |
| Arcobacter | 1 | 2017 | 4 | 0.19 | Why? |
| Siadenovirus | 1 | 2017 | 3 | 0.19 | Why? |
| Condylomata Acuminata | 1 | 2018 | 62 | 0.18 | Why? |
| Mardivirus | 1 | 2017 | 5 | 0.18 | Why? |
| Nipah Virus | 1 | 2019 | 121 | 0.18 | Why? |
| Whole Body Imaging | 1 | 2019 | 116 | 0.18 | Why? |
| Pyrethrins | 1 | 2017 | 28 | 0.18 | Why? |
| Lythraceae | 1 | 2018 | 14 | 0.18 | Why? |
| Eutheria | 1 | 2020 | 313 | 0.18 | Why? |
| Neoplasms, Multiple Primary | 1 | 2019 | 61 | 0.18 | Why? |
| Glutamates | 1 | 2017 | 12 | 0.18 | Why? |
| Animal Diseases | 1 | 2021 | 182 | 0.18 | Why? |
| Henipavirus Infections | 1 | 2019 | 122 | 0.18 | Why? |
| Anseriformes | 1 | 2017 | 32 | 0.18 | Why? |
| Turkeys | 1 | 2017 | 65 | 0.18 | Why? |
| Airports | 1 | 2020 | 284 | 0.18 | Why? |
| Antibody-Dependent Enhancement | 2 | 2021 | 413 | 0.18 | Why? |
| Estrogens | 1 | 2021 | 252 | 0.18 | Why? |
| Camellia sinensis | 1 | 2017 | 30 | 0.18 | Why? |
| Heat Stress Disorders | 1 | 2018 | 49 | 0.17 | Why? |
| Herbal Medicine | 1 | 2018 | 69 | 0.17 | Why? |
| Fishes | 1 | 2017 | 99 | 0.17 | Why? |
| Communicable Diseases, Emerging | 3 | 2020 | 2523 | 0.17 | Why? |
| Oropharyngeal Neoplasms | 1 | 2018 | 138 | 0.17 | Why? |
| Foodborne Diseases | 1 | 2017 | 89 | 0.16 | Why? |
| Mink | 1 | 2021 | 399 | 0.16 | Why? |
| Vaccines | 3 | 2021 | 3692 | 0.16 | Why? |
| Anti-Inflammatory Agents | 4 | 2020 | 6153 | 0.16 | Why? |
| Adenoviridae Infections | 1 | 2017 | 150 | 0.16 | Why? |
| Functional Food | 1 | 2018 | 122 | 0.16 | Why? |
| Candida albicans | 1 | 2018 | 217 | 0.16 | Why? |
| Tinospora | 1 | 2017 | 60 | 0.16 | Why? |
| Genetic Counseling | 1 | 2019 | 229 | 0.16 | Why? |
| Bird Diseases | 1 | 2017 | 130 | 0.16 | Why? |
| Dogs | 2 | 2020 | 2529 | 0.15 | Why? |
| Herpesviridae Infections | 1 | 2017 | 172 | 0.15 | Why? |
| Chiroptera | 2 | 2020 | 3530 | 0.15 | Why? |
| Biological Evolution | 1 | 2021 | 641 | 0.15 | Why? |
| Betacoronavirus | 15 | 2020 | 204454 | 0.14 | Why? |
| Mammography | 1 | 2019 | 410 | 0.14 | Why? |
| Ferrets | 1 | 2020 | 1201 | 0.14 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 3 | 2021 | 8843 | 0.14 | Why? |
| Coronavirus Infections | 19 | 2021 | 253789 | 0.14 | Why? |
| Papillomaviridae | 1 | 2018 | 404 | 0.14 | Why? |
| Air Travel | 1 | 2020 | 585 | 0.13 | Why? |
| Antiviral Agents | 8 | 2021 | 41703 | 0.13 | Why? |
| Family Health | 1 | 2019 | 731 | 0.13 | Why? |
| Immunization Programs | 3 | 2021 | 2006 | 0.13 | Why? |
| Candidiasis | 1 | 2018 | 334 | 0.13 | Why? |
| Stress, Physiological | 1 | 2018 | 378 | 0.13 | Why? |
| Vaccination | 6 | 2021 | 19050 | 0.13 | Why? |
| Papillomavirus Vaccines | 1 | 2018 | 405 | 0.13 | Why? |
| Immunotherapy | 3 | 2021 | 2421 | 0.12 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2017 | 398 | 0.12 | Why? |
| Adaptive Immunity | 2 | 2021 | 2585 | 0.12 | Why? |
| Camelus | 1 | 2020 | 1425 | 0.11 | Why? |
| Water Pollutants, Chemical | 1 | 2017 | 410 | 0.11 | Why? |
| Humans | 56 | 2021 | 930598 | 0.11 | Why? |
| Pandemics | 24 | 2021 | 389249 | 0.11 | Why? |
| Milk, Human | 1 | 2020 | 956 | 0.11 | Why? |
| CRISPR-Cas Systems | 1 | 2020 | 1397 | 0.11 | Why? |
| Animals, Zoo | 2 | 2021 | 106 | 0.11 | Why? |
| Disinfectants | 1 | 2021 | 1077 | 0.11 | Why? |
| Ebolavirus | 1 | 2017 | 834 | 0.11 | Why? |
| Dengue Virus | 1 | 2018 | 910 | 0.11 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.11 | Why? |
| Macaca mulatta | 1 | 2020 | 3716 | 0.10 | Why? |
| Cross Reactions | 2 | 2020 | 4374 | 0.10 | Why? |
| BCG Vaccine | 1 | 2020 | 1137 | 0.10 | Why? |
| Uterine Cervical Neoplasms | 1 | 2018 | 842 | 0.10 | Why? |
| Papillomavirus Infections | 1 | 2018 | 861 | 0.10 | Why? |
| Immune Evasion | 1 | 2020 | 2081 | 0.10 | Why? |
| Drug Delivery Systems | 1 | 2019 | 1365 | 0.09 | Why? |
| Kidney Diseases | 1 | 2020 | 1434 | 0.09 | Why? |
| Dexamethasone | 1 | 2020 | 2055 | 0.09 | Why? |
| Immunoglobulins, Intravenous | 1 | 2020 | 2705 | 0.09 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
| Early Detection of Cancer | 1 | 2019 | 1956 | 0.08 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.08 | Why? |
| Peptides | 1 | 2018 | 2513 | 0.08 | Why? |
| Dietary Supplements | 1 | 2019 | 2251 | 0.08 | Why? |
| Infectious bronchitis virus | 1 | 2014 | 856 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.08 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2021 | 5164 | 0.08 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.08 | Why? |
| SARS Virus | 2 | 2020 | 13021 | 0.08 | Why? |
| Biological Products | 1 | 2020 | 2331 | 0.08 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.07 | Why? |
| Dengue | 1 | 2018 | 1565 | 0.07 | Why? |
| Brain Ischemia | 1 | 2021 | 2813 | 0.07 | Why? |
| Zika Virus | 1 | 2018 | 1924 | 0.07 | Why? |
| Pregnancy Complications, Infectious | 2 | 2021 | 11559 | 0.07 | Why? |
| Pharmaceutical Preparations | 1 | 2019 | 1897 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2018 | 1920 | 0.07 | Why? |
| Immunization, Passive | 4 | 2021 | 10067 | 0.07 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.07 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.07 | Why? |
| Public Health | 4 | 2021 | 16359 | 0.06 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.06 | Why? |
| Ultrasonography | 1 | 2019 | 4409 | 0.06 | Why? |
| Disease Models, Animal | 1 | 2020 | 10998 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2019 | 6551 | 0.06 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.06 | Why? |
| Cloning, Organism | 1 | 2021 | 21 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| RNA, Transfer | 1 | 2021 | 66 | 0.06 | Why? |
| Embryonic Stem Cells | 1 | 2021 | 66 | 0.06 | Why? |
| Chickens | 2 | 2019 | 1010 | 0.05 | Why? |
| Breast Milk Expression | 1 | 2020 | 49 | 0.05 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.05 | Why? |
| Farms | 1 | 2021 | 269 | 0.05 | Why? |
| Random Amplified Polymorphic DNA Technique | 1 | 2018 | 8 | 0.05 | Why? |
| Geese | 1 | 2017 | 29 | 0.05 | Why? |
| Cyclooxygenase Inhibitors | 1 | 2018 | 46 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Plants | 1 | 2020 | 247 | 0.04 | Why? |
| Genomic Instability | 1 | 2018 | 80 | 0.04 | Why? |
| Polymorphism, Restriction Fragment Length | 1 | 2018 | 116 | 0.04 | Why? |
| Cloning, Molecular | 1 | 2021 | 1036 | 0.04 | Why? |
| Ducks | 1 | 2017 | 120 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Plant Oils | 1 | 2018 | 86 | 0.04 | Why? |
| Multilocus Sequence Typing | 1 | 2018 | 264 | 0.04 | Why? |
| Pesticides | 1 | 2017 | 100 | 0.04 | Why? |
| Molecular Typing | 1 | 2018 | 280 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.04 | Why? |
| Nepal | 1 | 2021 | 1004 | 0.04 | Why? |
| Enteritis | 1 | 2017 | 147 | 0.04 | Why? |
| Communicable Disease Control | 3 | 2020 | 29620 | 0.04 | Why? |
| Antineoplastic Agents, Phytogenic | 1 | 2018 | 183 | 0.04 | Why? |
| Antibodies, Bispecific | 1 | 2018 | 207 | 0.04 | Why? |
| Cross Protection | 1 | 2018 | 373 | 0.04 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.04 | Why? |
| Angiotensin II | 1 | 2021 | 601 | 0.04 | Why? |
| Sewage | 1 | 2020 | 591 | 0.04 | Why? |
| Rivers | 1 | 2017 | 304 | 0.04 | Why? |
| Virulence Factors | 1 | 2018 | 338 | 0.04 | Why? |
| Medicine, Traditional | 1 | 2017 | 189 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2018 | 556 | 0.04 | Why? |
| Neuroprotective Agents | 1 | 2017 | 240 | 0.04 | Why? |
| B-Lymphocytes | 2 | 2021 | 4418 | 0.04 | Why? |
| Environment | 1 | 2021 | 769 | 0.03 | Why? |
| Patents as Topic | 1 | 2017 | 224 | 0.03 | Why? |
| Child, Hospitalized | 1 | 2018 | 556 | 0.03 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2018 | 691 | 0.03 | Why? |
| Virus Attachment | 1 | 2021 | 1259 | 0.03 | Why? |
| T-Lymphocytes | 2 | 2021 | 6670 | 0.03 | Why? |
| Dog Diseases | 1 | 2019 | 745 | 0.03 | Why? |
| Child | 2 | 2019 | 70012 | 0.03 | Why? |
| Global Health | 3 | 2020 | 13911 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2019 | 25144 | 0.03 | Why? |
| Receptors, Interleukin-6 | 1 | 2020 | 1383 | 0.03 | Why? |
| Phylogeny | 2 | 2021 | 13341 | 0.03 | Why? |
| Feasibility Studies | 1 | 2021 | 3467 | 0.03 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Molecular Targeted Therapy | 1 | 2020 | 1579 | 0.03 | Why? |
| Clinical Trials as Topic | 2 | 2020 | 7330 | 0.03 | Why? |
| Ivermectin | 1 | 2020 | 973 | 0.03 | Why? |
| Aged | 4 | 2020 | 215776 | 0.03 | Why? |
| Sentinel Surveillance | 1 | 2017 | 1093 | 0.03 | Why? |
| Saudi Arabia | 1 | 2021 | 4423 | 0.03 | Why? |
| Waste Water | 1 | 2020 | 2185 | 0.02 | Why? |
| Breast Feeding | 1 | 2020 | 1585 | 0.02 | Why? |
| Immune System | 1 | 2018 | 1479 | 0.02 | Why? |
| Immunomodulation | 1 | 2018 | 1472 | 0.02 | Why? |
| Female | 5 | 2021 | 380317 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Pregnancy | 2 | 2021 | 23879 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.02 | Why? |
| Disinfection | 1 | 2021 | 2912 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2020 | 4020 | 0.02 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.02 | Why? |
| Cross Infection | 2 | 2021 | 8675 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Drug Design | 1 | 2018 | 2627 | 0.02 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.02 | Why? |
| Renal Insufficiency, Chronic | 1 | 2020 | 2654 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.02 | Why? |
| Male | 3 | 2021 | 367725 | 0.02 | Why? |
| Tuberculosis | 1 | 2020 | 2895 | 0.02 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.02 | Why? |
| India | 1 | 2021 | 11875 | 0.02 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.02 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Adult | 1 | 2019 | 244371 | 0.01 | Why? |
| Middle Aged | 1 | 2019 | 270681 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Diagnosis, Differential | 1 | 2014 | 7220 | 0.01 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Virus Replication | 1 | 2014 | 14331 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |